Vortioxetine as adjunctive therapy in the treatment of schizophrenia.
Sofia RedaelliLilla PorffyEbenezer OloyedeOlubanke DzahiniGabriella LewisMaria LoboEromona WhiskeySukhi S ShergillPublished in: Therapeutic advances in psychopharmacology (2022)
Schizophrenia is a complex illness, and there is insufficient treatment response in many individuals. A significant proportion of whom may require adjunctive treatments depending on the nature of the residual symptoms. Vortioxetine could be a potentially safe and effective option in such people, but further controlled studies are required.